Physician profile
Nancy Heine
NPI 1205090875
$3,504.77
in general payments reported to CMS, 2019-2025
12 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.62 · 2020: $254 · 2021: $511 · 2022: $1,418 · 2023: $637 · 2024: $276 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,260.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,343.92 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $576.00 | 2020-2025 | Dailies Total1, Precision 1, Dailies |
| Novartis Pharmaceuticals Corporation | $122.33 | 2020-2022 | |
| Abbvie INC. | $119.07 | 2022-2023 | |
| Tarsus Pharmaceuticals, INC. | $63.44 | 2024 | Xdemvy |
| Oyster Point Pharma, INC. | $63.27 | 2022-2023 | Tyrvaya |
| Dompe US, INC. | $55.91 | 2024-2025 | Oxervate |
| Kala Pharmaceuticals, INC. | $43.10 | 2021 | |
| Abb Con-Cise Optical Group LLC | $41.11 | 2021 | |
| Bausch & Lomb Americas INC. | $39.47 | 2024-2025 | Infuse |
| Allergan, INC. | $26.10 | 2022 | |
| Coopervision INC. | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Heine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.